Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX plus /- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials.

Affiliation auteurs!!!! Error affiliation !!!!
TitrePrognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX plus /- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials.
Type de publicationJournal Article
Year of Publication2015
AuteursTaieb J, Le Malicot K, Penault-Llorca FMadeleine, Bouche O, Shi Q, Thibodeau SN, Tabernero J, Mini E, Goldberg RM, Folprecht G, Van Laethem J-L, Sargent DJ, Alberts SR, Laurent-Puig P, Sinicrope FA
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.15_suppl.3507